130 related articles for article (PubMed ID: 24343405)
21. Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis.
Farris M; Bastianelli C; Rosato E; Brosens I; Benagiano G
Expert Rev Clin Pharmacol; 2017 Oct; 10(10):1129-1144. PubMed ID: 28712325
[TBL] [Abstract][Full Text] [Related]
22. Drospirenone: high risk of venous thrombosis.
Prescrire Int; 2011 Feb; 20(113):43-5. PubMed ID: 21488592
[TBL] [Abstract][Full Text] [Related]
23. The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI.
Raps M; Helmerhorst FM; Fleischer K; Dahm AE; Rosendaal FR; Rosing J; Reitsma P; Sandset PM; van Vliet HA
Thromb Haemost; 2013 Apr; 109(4):606-13. PubMed ID: 23407778
[TBL] [Abstract][Full Text] [Related]
24. Toward a new concept of "natural balance" in oral estroprogestin contraception.
Chabbert-Buffet N; Gerris J; Jamin C; Lello S; Lete I; Lobo P; Nappi RE; Pintiaux A
Gynecol Endocrinol; 2013 Oct; 29(10):891-6. PubMed ID: 23931030
[TBL] [Abstract][Full Text] [Related]
25. [Changed routines in connection with first prescription of oral contraceptives. Lower risk of venous thromboembolism with levonorgestrel preparations].
Milsom I; Odlind V; von Schoultz B; Ostlund I; Persson E
Lakartidningen; 2002 Jan; 99(1-2):10-2, 15. PubMed ID: 11871161
[No Abstract] [Full Text] [Related]
26. Instrumental variable analysis as a complementary analysis in studies of adverse effects: venous thromboembolism and second-generation versus third-generation oral contraceptives.
Boef AG; Souverein PC; Vandenbroucke JP; van Hylckama Vlieg A; de Boer A; le Cessie S; Dekkers OM
Pharmacoepidemiol Drug Saf; 2016 Mar; 25(3):317-24. PubMed ID: 26749045
[TBL] [Abstract][Full Text] [Related]
27. [Axillary vein thrombosis in a young woman with a contraceptive ring. Prothrombin gene mutation a possible connection].
Samuelsson E; Hultdin J; Groth K; Hedenmalm K
Lakartidningen; 2007 Jan 10-16; 104(1-2):32-4. PubMed ID: 17323737
[No Abstract] [Full Text] [Related]
28. [Combined oral contraception and hypercoagulation].
Adukauskiene D; Miliauskiene V
Medicina (Kaunas); 2010; 46(4):293-7. PubMed ID: 20571299
[TBL] [Abstract][Full Text] [Related]
29. Recurrent peritoneal inclusion cysts successfully treated with oral contraceptives: a report of two cases.
Yokoyama N; Yasuda R; Ichida K; Murakoshi H; Okada J; Yoshida S; Motoyama S
Clin Exp Obstet Gynecol; 2014; 41(1):83-6. PubMed ID: 24707692
[TBL] [Abstract][Full Text] [Related]
30. Are hormonal components of oral contraceptives associated with impaired female sexual function? A questionnaire-based online survey of medical students in Germany, Austria, and Switzerland.
Wallwiener CW; Wallwiener LM; Seeger H; Schönfisch B; Mueck AO; Bitzer J; Zipfel S; Brucker SY; Taran FA; Wallwiener M
Arch Gynecol Obstet; 2015 Oct; 292(4):883-90. PubMed ID: 25905601
[TBL] [Abstract][Full Text] [Related]
31. Rationale for eliminating the hormone-free interval in modern oral contraceptives.
London A; Jensen JT
Int J Gynaecol Obstet; 2016 Jul; 134(1):8-12. PubMed ID: 27067074
[TBL] [Abstract][Full Text] [Related]
32. Menstrual regulation by sequential hormone therapy.
Beaton JH
West J Surg Obstet Gynecol; 1964; 72():160-3. PubMed ID: 12332438
[TBL] [Abstract][Full Text] [Related]
33. Population Reports. Lower-dose pills.
Popul Rep A; 1988 Nov; (7):1-31. PubMed ID: 3076873
[No Abstract] [Full Text] [Related]
34. Pharmacodynamics of combined estrogen-progestin oral contraceptives: 1. Effects on metabolism.
Bastianelli C; Farris M; Rosato E; Brosens I; Benagiano G
Expert Rev Clin Pharmacol; 2017 Mar; 10(3):315-326. PubMed ID: 27977304
[TBL] [Abstract][Full Text] [Related]
35. Use of an oral contraceptive containing drospirenone in an extended regimen.
Sillem M; Schneidereit R; Heithecker R; Mueck AO
Eur J Contracept Reprod Health Care; 2003 Sep; 8(3):162-9. PubMed ID: 14667328
[TBL] [Abstract][Full Text] [Related]
36. Hormonal contraceptives: pharmacology tailored to women's health.
De Leo V; Musacchio MC; Cappelli V; Piomboni P; Morgante G
Hum Reprod Update; 2016 Sep; 22(5):634-46. PubMed ID: 27307386
[TBL] [Abstract][Full Text] [Related]
37. Specific oral contraceptive use and venous thromboembolism resulting in hospital admission.
Heuser P; Tonga K; Hopkins R; Henderson M; Weatherall M; Metcalfe S; Beasley R
N Z Med J; 2004 Nov; 117(1206):U1176. PubMed ID: 15570345
[TBL] [Abstract][Full Text] [Related]
38. Hormonal contraception, thrombosis and age.
Lidegaard Ø
Expert Opin Drug Saf; 2014 Oct; 13(10):1353-60. PubMed ID: 25227335
[TBL] [Abstract][Full Text] [Related]
39. [Clinical study of the use of a new tri-phasic pill].
Giobbe C; Piacentino R; Marchino GL; Zaccheo F; Cellura A; Ferrara L; Mazza O; Caccuri D; Condello V; Grio R
Minerva Ginecol; 1990 Nov; 42(11):463-6. PubMed ID: 2080034
[TBL] [Abstract][Full Text] [Related]
40. Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment.
Stanczyk FZ; Archer DF; Bhavnani BR
Contraception; 2013 Jun; 87(6):706-27. PubMed ID: 23375353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
